BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 37289451)

  • 1. Risk Factors for Progression and Toxic Effects After Preoperative Stereotactic Radiosurgery for Patients With Resected Brain Metastases.
    Prabhu RS; Akinyelu T; Vaslow ZK; Matsui JK; Haghighi N; Dan T; Mishra MV; Murphy ES; Boyles S; Perlow HK; Palmer JD; Udovicich C; Patel TR; Wardak Z; Woodworth GF; Ksendzovsky A; Yang K; Chao ST; Asher AL; Burri SH
    JAMA Oncol; 2023 Aug; 9(8):1066-1073. PubMed ID: 37289451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-Fraction Versus Fractionated Preoperative Radiosurgery for Resected Brain Metastases: A PROPS-BM International Multicenter Cohort Study.
    Prabhu RS; Akinyelu T; Vaslow ZK; Matsui JK; Haghighi N; Dan T; Mishra MV; Murphy ES; Boyles S; Perlow HK; Palmer JD; Udovicich C; Patel TR; Wardak Z; Woodworth GF; Ksendzovsky A; Yang K; Chao ST; Asher AL; Burri SH
    Int J Radiat Oncol Biol Phys; 2024 Mar; 118(3):650-661. PubMed ID: 37717787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative Radiosurgery for Resected Brain Metastases: The PROPS-BM Multicenter Cohort Study.
    Prabhu RS; Dhakal R; Vaslow ZK; Dan T; Mishra MV; Murphy ES; Patel TR; Asher AL; Yang K; Manning MA; Stern JD; Patel AR; Wardak Z; Woodworth GF; Chao ST; Mohammadi A; Burri SH
    Int J Radiat Oncol Biol Phys; 2021 Nov; 111(3):764-772. PubMed ID: 34058254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-Fraction Stereotactic Radiosurgery (SRS) Alone Versus Surgical Resection and SRS for Large Brain Metastases: A Multi-institutional Analysis.
    Prabhu RS; Press RH; Patel KR; Boselli DM; Symanowski JT; Lankford SP; McCammon RJ; Moeller BJ; Heinzerling JH; Fasola CE; Asher AL; Sumrall AL; Buchwald ZS; Curran WJ; Shu HG; Crocker I; Burri SH
    Int J Radiat Oncol Biol Phys; 2017 Oct; 99(2):459-467. PubMed ID: 28871997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative stereotactic radiosurgery before planned resection of brain metastases: updated analysis of efficacy and toxicity of a novel treatment paradigm.
    Prabhu RS; Miller KR; Asher AL; Heinzerling JH; Moeller BJ; Lankford SP; McCammon RJ; Fasola CE; Patel KR; Press RH; Sumrall AL; Ward MC; Burri SH
    J Neurosurg; 2018 Dec; 131(5):1387-1394. PubMed ID: 30554174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early Gamma Knife stereotactic radiosurgery to the tumor bed of resected brain metastasis for improved local control.
    Iorio-Morin C; Masson-Côté L; Ezahr Y; Blanchard J; Ebacher A; Mathieu D
    J Neurosurg; 2014 Dec; 121 Suppl():69-74. PubMed ID: 25434939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing Preoperative With Postoperative Stereotactic Radiosurgery for Resectable Brain Metastases: A Multi-institutional Analysis.
    Patel KR; Burri SH; Asher AL; Crocker IR; Fraser RW; Zhang C; Chen Z; Kandula S; Zhong J; Press RH; Olson JJ; Oyesiku NM; Wait SD; Curran WJ; Shu HK; Prabhu RS
    Neurosurgery; 2016 Aug; 79(2):279-85. PubMed ID: 26528673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial.
    Brown PD; Ballman KV; Cerhan JH; Anderson SK; Carrero XW; Whitton AC; Greenspoon J; Parney IF; Laack NNI; Ashman JB; Bahary JP; Hadjipanayis CG; Urbanic JJ; Barker FG; Farace E; Khuntia D; Giannini C; Buckner JC; Galanis E; Roberge D
    Lancet Oncol; 2017 Aug; 18(8):1049-1060. PubMed ID: 28687377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase III, multicenter, randomized controlled trial of preoperative versus postoperative stereotactic radiosurgery for patients with surgically resectable brain metastases.
    Das S; Faruqi S; Nordal R; Starreveld Y; Kelly J; Bowden G; Amanie J; Fairchild A; Lim G; Loewen S; Rowe L; Wallace C; Ghosh S; Patel S
    BMC Cancer; 2022 Dec; 22(1):1368. PubMed ID: 36585629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereotactic radiosurgery to the resection bed for intracranial metastases and risk of leptomeningeal carcinomatosis.
    Ojerholm E; Lee JY; Thawani JP; Miller D; O'Rourke DM; Dorsey JF; Geiger GA; Nagda S; Kolker JD; Lustig RA; Alonso-Basanta M
    J Neurosurg; 2014 Dec; 121 Suppl():75-83. PubMed ID: 25434940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereotactic Radiosurgery for Differentiated Thyroid Cancer Brain Metastases: An International, Multicenter Study.
    Bunevicius A; Fribance S; Pikis S; Lee JYK; Buch LY; Moran M; Yang AI; Bernstein K; Mathieu D; Perron R; Liscak R; Simonova G; Patel S; Trifiletti DM; Martínez Álvarez R; Martínez Moreno N; Lee CC; Yang HC; Strickland BA; Zada G; Chang EL; Kondziolka D; Sheehan J
    Thyroid; 2021 Aug; 31(8):1244-1252. PubMed ID: 33978475
    [No Abstract]   [Full Text] [Related]  

  • 12. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
    Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
    J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of preoperative versus postoperative treatment dosimetry plans of single-fraction stereotactic radiosurgery for surgically resected brain metastases.
    Cheok SK; Yu C; Feng JJ; Briggs RG; Chow F; Hwang L; Ye JC; Attenello FJ; Tran D; Chang E; Zada G
    Neurosurg Focus; 2023 Aug; 55(2):E9. PubMed ID: 37527673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-institutional Analysis of Prognostic Factors and Outcomes After Hypofractionated Stereotactic Radiotherapy to the Resection Cavity in Patients With Brain Metastases.
    Eitz KA; Lo SS; Soliman H; Sahgal A; Theriault A; Pinkham MB; Foote MC; Song AJ; Shi W; Redmond KJ; Gui C; Kumar AMS; Machtay M; Meyer B; Combs SE
    JAMA Oncol; 2020 Dec; 6(12):1901-1909. PubMed ID: 33057566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereotactic radiosurgery for intracranial hemangiopericytomas: a multicenter study.
    Cohen-Inbar O; Lee CC; Mousavi SH; Kano H; Mathieu D; Meola A; Nakaji P; Honea N; Johnson M; Abbassy M; Mohammadi AM; Silva D; Yang HC; Grills I; Kondziolka D; Barnett GH; Lunsford LD; Sheehan J
    J Neurosurg; 2017 Mar; 126(3):744-754. PubMed ID: 27104850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of regular magnetic resonance imaging follow-up after stereotactic radiotherapy to the surgical cavity in patients with one to three brain metastases.
    Bachmann N; Leiser D; Ermis E; Vulcu S; Schucht P; Raabe A; Aebersold DM; Herrmann E
    Radiat Oncol; 2019 Mar; 14(1):45. PubMed ID: 30871597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging-defined necrosis after treatment with single-fraction stereotactic radiosurgery and immune checkpoint inhibitors and its potential association with improved outcomes in patients with brain metastases: an international multicenter study of 697 patients.
    Lehrer EJ; Ahluwalia MS; Gurewitz J; Bernstein K; Kondziolka D; Niranjan A; Wei Z; Lunsford LD; Fakhoury KR; Rusthoven CG; Mathieu D; Trudel C; Malouff TD; Ruiz-Garcia H; Bonney P; Hwang L; Yu C; Zada G; Patel S; Deibert CP; Picozzi P; Franzini A; Attuati L; Prasad RN; Raval RR; Palmer JD; Lee CC; Yang HC; Jones BM; Green S; Sheehan JP; Trifiletti DM
    J Neurosurg; 2023 May; 138(5):1178-1187. PubMed ID: 36115055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postoperative stereotactic radiosurgery without whole-brain radiation therapy for brain metastases: potential role of preoperative tumor size.
    Hartford AC; Paravati AJ; Spire WJ; Li Z; Jarvis LA; Fadul CE; Rhodes CH; Erkmen K; Friedman J; Gladstone DJ; Hug EB; Roberts DW; Simmons NE
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):650-5. PubMed ID: 22795806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A matched-pair analysis of clinical outcomes after intracavitary cesium-131 brachytherapy versus stereotactic radiosurgery for resected brain metastases.
    Julie DA; Lazow SP; Vanderbilt DB; Taube S; Yondorf MZ; Sabbas A; Pannullo S; Schwartz TH; Wernicke AG
    J Neurosurg; 2020 May; 134(5):1447-1454. PubMed ID: 32413856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases ≥ 2 cm.
    Angelov L; Mohammadi AM; Bennett EE; Abbassy M; Elson P; Chao ST; Montgomery JS; Habboub G; Vogelbaum MA; Suh JH; Murphy ES; Ahluwalia MS; Nagel SJ; Barnett GH
    J Neurosurg; 2018 Aug; 129(2):366-382. PubMed ID: 28937324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.